MN Services Vermogensbeheer’s Alnylam Pharmaceuticals ALNY Stock Holding History

MN Services Vermogensbeheer’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.7M	Buy	+38,700	New	+$11.7M	0.09%	209
2019 Q3	–	Sell	-15,400	Closed	-$1.12M	–	355
2019 Q2	$1.12M	Hold	15,400	–	–	0.01%	612
2019 Q1	$1.44M	Hold	15,400	–	–	0.02%	555
2018 Q4	$982K	Buy	15,400 +100	+0.7%	+$7.69K	0.01%	563
2018 Q3	$1.34M	Buy	15,300 +1,500	+11%	+$151K	0.03%	551
2018 Q2	$1.36M	Hold	13,800	–	–	0.03%	541
2018 Q1	$1.64M	Hold	13,800	–	–	0.04%	473
2017 Q4	$1.46M	Buy	+13,800	New	+$1.73M	0.05%	442
2016 Q4	–	Sell	-1,974	Closed	-$134K	–	623
2016 Q3	$134K	Buy	1,974 +87	+5%	+$6.14K	0.03%	569
2016 Q2	$94K	Hold	1,887	–	–	0.02%	595
2016 Q1	$104K	Buy	+1,887	New	+$125K	0.02%	622

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MN Services Vermogensbeheer's ALNY Position: Q2 2026 in Review

MN Services Vermogensbeheer opened a new position in Alnylam Pharmaceuticals (ALNY) in Q2 2026: 38,700 shares worth $11.7M. The stake represents 0.09% of the portfolio and ranks #209 among its holdings. This is a return to the name: MN Services Vermogensbeheer previously reported a position in ALNY as recently as Q2 2019.

MN Services Vermogensbeheer first reported a position in ALNY in Q1 2016 and has held it in 11 quarters since. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

MN Services Vermogensbeheer held 38,700 shares of Alnylam Pharmaceuticals worth $11.7M as of Q2 2026.
Alnylam Pharmaceuticals was a new MN Services Vermogensbeheer position in Q2 2026.
Alnylam Pharmaceuticals made up 0.09% of MN Services Vermogensbeheer's portfolio in Q2 2026, its #209 holding.
MN Services Vermogensbeheer first reported a position in Alnylam Pharmaceuticals in Q1 2016 and has held it in 11 quarters since.
790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on MN Services Vermogensbeheer's 13F filing for Q2 2026, filed 31 Jul 2026.